Trials / Completed
CompletedNCT00165815
The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- —
Summary
A randomised, double-blind, 3-arm parallel group study comparing Aricept® with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARICEPT |
Timeline
- Start date
- 2002-08-01
- Completion
- 2005-07-01
- First posted
- 2005-09-14
- Last updated
- 2013-05-10
Locations
4 sites across 2 countries: Germany, Ireland
Source: ClinicalTrials.gov record NCT00165815. Inclusion in this directory is not an endorsement.